Evidence-based clinical practice guidelines for bladder cancer (summary - JUA 2009 Edition).
In Japan, until now, the treatment of bladder cancer has been based on guidelines from overseas. The problem with this practice is that the options recommended in overseas guidelines are not necessarily suitable for Japanese clinical practice. A relatively large number of clinical trials have been conducted in Japan in the field of bladder cancer, and the Japanese Urological Association (JUA) considered it appropriate to formulate their own guidelines. These Guidelines present an overview of bladder cancer at each clinical stage, followed by clinical questions that address problems frequently faced in everyday clinical practice. In this English translation of a shortened version of the original Guidelines, we have abridged each overview, summarized each clinical question and its answer, and only included the references we considered of particular importance.
D044466:Asian People; D019317:Evidence-Based Medicine; D006801:Humans; D007564:Japan; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*